Synthesis and Crystal Structure of 2-Amino- 5,6-dihydro-4-（3,4-dimethoxyphenyl）-4H- benzo[h]chromene-3-carbonitrile

1 INTRODUCTION 2-Aminochromene is an important class of com- pounds found as the main compounds of many natu- rally occurring products employed as cosmetics and pigments and utilized as potential biodegradeable agro- chemicals[1～3]. In recent years, montmorillonite in natural and ex- changed forms has received considerable attention in different organic syntheses because of its environ- mental compatibility, low cost, high selectivity, reusa- bility and operational simplicity[4], such as …     

乳液聚合法制备水分散有机硅聚合物

乳液聚合法是制备水性有机硅聚合物的最有效、最常用的方法。本文从乳液聚合所采用的有机硅单体或预聚物、乳液聚合工艺、乳液体系的稳定性等方面，论述了采用乳液聚合法合成水性有机硅聚合物领域所面临的问题及所取得的研究进展。     

羧甲基壳聚糖/明胶共混膜的结构表征与吸湿保湿性

壳聚糖通过羧甲基化得到水溶性N，O-羧甲基壳聚糖，并将其配制成4Wt％水溶液，与4Wt％明胶水溶液共混，成功制得了羧甲基壳聚糖／明胶共混膜。采用红外光谱、x射线衍射、扫描电镜对共混膜进行结构表征，结果表明，共混膜中羧甲基壳聚糖和明胶分子间存在着较强的相互作用及良好的相容性。通过共混膜的力学性能测试，发现当羧甲基壳聚糖含量为20％时，共混膜的抗张强度达到最大值(75MPa)，分别比单独的羧甲基壳聚糖(45MPa)和明胶(43MPa)提高了66．7％和74％。经过吸湿和保湿性能测试，发现当羧甲基壳聚糖含量为80％时，吸湿率和保湿率分别为33．4％和69．2％，比单独的明胶膜分别提高了1．8倍和2．1倍。     

Synthesis and Crystal Structure of 9-（ 4-M e tho xylphen yl ）-1,8-dioxo-3,4,5,6,7,9hexahydroxanthene under Microwave Irradiation

1INTRODUCTIONInthepastfewyears,potassiumchannelacti-vatorshavegainedincreasingattentionbecauseoftheirclinicalpotentialapplicationsinvariousdiseases.Oneofthemostpotentcompoundsamongthisnewclassofdrugsisthebenzopyranderivativecroma-kalim[1～4].Benzopyranaswellasitsderivativesex-hibitsextensivepharmacologicalandbiologicalacti-vities[5],suchasantibacterialactivities[6,,antitumor7]activity[8],hypotensiveeffect[9],antiproliferationef-fect[10],etc.Thetitlecompoundbearingabenzo-pyranstructuraluni…     

微波辐射下4-(4-羟基-3-甲氧基)苯基-3,3,6,6-四甲基-1,8-二氧代1,2,3,4,5,6,7,8,9,10-十氢吖啶的合成和晶体结构

标题化合物C24H29NO4?1/2C2H5OH稨2O)由香兰素、5,5-二甲基-1,3-环己二酮、醋酸铵在微波辐射下干反应并经95%乙醇重结晶而得C24H29NO4穀2(C2H5OH稨2O)晶体。结构通过单晶X-射线衍射法确定,其晶体属单斜晶系,空间群P21/n, a = 9.810(2), b = 14.516(3), c = 17.008(3) ? b = 101.03(2), V = 2377.2(8) ?, Z = 4, Mr = 427.52, Dc = 1.195 g/cm3 , m(MoKa) = 0.082 mm-1, F(000) = 920。晶体结构用直接法解出,经全矩阵最小二乘法对原子参数进行修正,最终的偏离因子为R = 0.0406, wR = 0.0892。X-射线衍射分析结果表明,吡啶环和与之稠合的2个六员环均为信封式构象。     

在离子液体中一步法合成吡唑[5,4-b]-γ-吡喃衍生物

芳醛、丙二腈与4,5-二氢-3-甲基-5-氧代-1-苯基吡唑在离子液体[bmim][BF₄]中反应, 合成了2-氨基-4-芳基-3-氰基-5-甲基-7-苯基吡唑[5,4-b]-γ-吡喃衍生物, 该法快速、高效, 是一种洁净的合成方法. 产物的结构通过红外光谱、核磁共振氢谱和元素分析进行表征.     

Synthesis and Crystal Structure of 3,3,6,6-Tetramethyl-N-hydroxy-9-ethyl-1,8-dioxo-1,2,3,4,5,6,7,8,9,10-decahydroacridine

1 INTRODUCTION 1,4-Dihydropyridines (1,4-DHPs) are well-knowncompounds because of their pharmacological pro-perty as calcium channel modulators[1, . The che- 2]mical modifications, such as the introduction of dif-ferent substituents[3, or heteroatoms[5], of the DHP 4]ring have allowed the expansion of researches onthe structure-activity relationship to gain new in-sights into the molecular interactions at the receptorlevel. In fact, it is well established th…     

高分子固载化Lewis酸催化剂——聚苯乙烯-三氯化铝/四氯化钛复合物

<正> 均相催化剂的固载化是目前催化剂研究方向之一。Skct等首次将BF_5和AlCl_3分别与苯乙烯反应制成高分子催化剂,对酯化、缩醛、缩酮等有机反应具有良好的催化作用。我们曾将四氯化钛与聚苯乙烯反应制成一种稳定复合物,有良好的催化效能。为了改进其重复使用性能,本文将等摩尔的AlCl_3,和TiCl_4的Lewis酸同时与聚苯乙烯交     

以催化油浆窄馏分为添加剂的Al－MCM－41分子筛的合成

 采用阳离子表面活性剂十六烷基三甲基溴化铵为模板剂，以正硅酸乙酯为硅源，以硫酸铝为铝源，水热合成了以催化油浆窄馏分为添加剂的高比表面积Al－MCM－41介孔分子筛，并利用XRD，HREM，TG－DTA及N2吸附－脱附等测试手段对合成样品进行了表征．合成的Al－MCM－41分子筛的比表面积和孔体积分别达到1295m2／g和1．5cm3／g，其平均孔径为4．3nm．重点研究了Al－MCM－41分子筛结晶度、晶胞参数、比表面积、孔体积及平均孔径等结构性质随催化油浆窄馏分添加量及其组成的变化规律，并从合成机理上进行了解释．     

Synthesis and Crystal Structure of N-cyclopropyl-9 -（3,4-dicholophenyl）- 1,2,3,4,5,6,7,8,9,10-decahydroacridine -1,8-dione under Microwave Irradiation

1 INTRODUCTION aryl or methyl group to the nitrogen atom of these compounds leads to enhanced activities of fluo- A lot of natural and synthetic compounds con- rescence[7, . Since the pyridine scaffold is included 8] taining acridine skeletons display interesting biolo- in decahydroacridine-1,8-dione, a question is whether gical and physical activities[1]. Acridinedione, for the same modification on the nitrogen atom of de- example, has been identified as antimalarial and cahydroacridine-1…